Viatris is a finished-dose manufacturer based in Norway. It appears in 3,635 regulatory filings across 10 regulators, without an active US DMF or CEP on file. Its filings concentrate with MEDSAFE (NZ), EMA and AIFA (IT). Its GMP standing is certified by HSA (SG).
| Regulator | Filings | GMP certificates |
|---|---|---|
| MEDSAFE (NZ) | 848 | None |
| EMA | 624 | None |
| AIFA (IT) | 585 | None |
| INFARMED (PT) | 524 | None |
| FAMHP (BE) | 505 | None |
| MPA (SE) | 344 | None |
| HSA (SG) | None | 2 |
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Choose your molecules and target markets. Viatris comes back tiered against every other supplier able to file there.
Start for free